1+1.232x2-0.099x3+ 0.091x4-1.292x5-1.825x6-0.911x7, (2) where x1 is age in years; x2 is presence of cardiovascular disease: no - x2 = 0, yes - x2 = 1; x3 is systolic blood pressure in mmHg; x4 is diastolic blood pressure in mmHg; x5 is presence of POAG with relatives: no - x5 = 0, yes - x5= 1; x6 is presence of comorbidity eye: no - x6 = 0, yes - x6 = 1; x7 is genetic variant locus -308G/A TNFα: for option AA- x7 = 1 for variant AG- x7 = 2, for option GG- x7 = 3. If P is greater than 60 - predict risk of developing POAG with ineffective conservative therapy, if P is less than 40 - predict effectiveness of conservative treatment of POAG, if P is greater than 40 but less than 60 - more thorough dynamic follow up is necessary.;EFFECT: essence of method lies in that it includes isolation of DNA from peripheral venous blood.;1 cl, 2 dwg, 3 ex"/> METHOD FOR PREDICTION OF RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITH INEFFECTIVE CONSERVATIVE THERAPY
首页> 外国专利> METHOD FOR PREDICTION OF RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITH INEFFECTIVE CONSERVATIVE THERAPY

METHOD FOR PREDICTION OF RISK OF DEVELOPING PRIMARY OPEN-ANGLE GLAUCOMA WITH INEFFECTIVE CONSERVATIVE THERAPY

机译:保守治疗无效的原发性开角型青光眼的风险预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine and concerns a method for predicting risk of primary open angle glaucoma (POAG) with ineffective conservative therapy in individuals of Russian nationality, who are natives of Central Black Soil Region of Russia. Method includes carrying out analysis of polymorphisms of TNFα (-308G/A TNFα) and predicting risk of POAG with ineffective conservative treatment, depending on options identified by locus of -308G/A TNFα and other predictors of development of disease according to equation: P=ey/(1+ey), (1) where "e" is a mathematical constant equal to 2.72; and "y" is calculated by logistic regression equation: y=15-0.099x1+1.232x2-0.099x3+ 0.091x4-1.292x5-1.825x6-0.911x7, (2) where x1 is age in years; x2 is presence of cardiovascular disease: no - x2 = 0, yes - x2 = 1; x3 is systolic blood pressure in mmHg; x4 is diastolic blood pressure in mmHg; x5 is presence of POAG with relatives: no - x5 = 0, yes - x5= 1; x6 is presence of comorbidity eye: no - x6 = 0, yes - x6 = 1; x7 is genetic variant locus -308G/A TNFα: for option AA- x7 = 1 for variant AG- x7 = 2, for option GG- x7 = 3. If P is greater than 60 - predict risk of developing POAG with ineffective conservative therapy, if P is less than 40 - predict effectiveness of conservative treatment of POAG, if P is greater than 40 but less than 60 - more thorough dynamic follow up is necessary.;EFFECT: essence of method lies in that it includes isolation of DNA from peripheral venous blood.;1 cl, 2 dwg, 3 ex
机译:技术领域本发明涉及医学,并且涉及一种方法,该方法通过保守的无效疗法在俄罗斯国籍的个体中预测原发性开角型青光眼(POAG)的风险,所述个体为俄罗斯中部黑土地区。方法包括对TNFα(-308G / ATNFα)的多态性进行分析,并根据保守的-308G / ATNFα基因座和其他预测疾病发生的预测因子,根据等式:P预测保守治疗无效的POAG风险= e y /(1 + e y ),(1)其中,“ e”是等于2.72的数学常数;和“ y”通过逻辑回归方程计算:y = 15-0.099x 1 + 1.232x 2 -0.099x 3 + 0.091x 4 -1.292x 5 -1.825x 6 -0.911x 7 ,(2)其中x 1 是年龄(以岁为单位); x 2 是否存在心血管疾病:否-x 2 = 0,是-x 2 = 1; x 3 是收缩压,单位为mmHg; x 4 是舒张压,单位为mmHg; x 5 是带有亲戚的POAG的存在:否-x 5 = 0,是-x 5 = 1; x 6 是合并症眼的存在:否-x 6 = 0,是-x 6 = 1; x 7 是遗传变异位点-308G / ATNFα:对于选项AA- x 7 = 1对于变异AG- x 7 = 2对于选项GG- x 7 =3。如果P大于60-预测无效保守疗法导致发生POAG的风险,如果P小于40-预测POAG保守治疗的有效性,如果P大于40但小于60-需要进行更彻底的动态跟进。效果:方法的实质在于从外周静脉血中分离DNA。1cl,2 dwg,3 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号